Article Details

Eosinophilic Esophagitis Drug Market Is Expected to Boom- AstraZeneca, GSK

Retrieved on: 2022-09-11 01:18:22

Tags for this article:

Click the tags to see associated articles and topics

Eosinophilic Esophagitis Drug Market Is Expected to Boom- AstraZeneca, GSK. View article details on HISWAI: https://www.fightinghawksmagazine.com/eosinophilic-esophagitis-drug-market-is-expected-to-boom-astrazeneca-gsk/

Excerpt

AstraZeneca, GSK, Bayer, Adare Pharmaceuticals, DBV Technologies, Dr. Falk Pharma, Quorum Innovations, Shire, Calypso, Celgene, Regeneron.

Article found on: www.fightinghawksmagazine.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up